Drug cocktail check: will new meds mess with a diabetes pill?

NCT ID NCT07213310

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed phase 1 study tested whether two experimental drugs, DWC202511 and DWC202512, change how the body processes the diabetes medicine DWP16001. Eighteen healthy adults took DWP16001 alone and then with each of the other drugs. The goal was to see if there are any drug interactions that could affect dosing or safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

DWP16001 (enavogliflozin), DWC202511, DWC202512

What this could lead to

If successful, this could help determine safe dosing when these drugs are taken together.

What could go wrong

This is a very early, small study in healthy people, not patients. Results may not predict real-world effects or safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Seoul National University Hospital

    Seoul, Jong No Gu, 03080, South Korea